节点文献

DMD基因和SRY基因单细胞三重及四重套式PCR技术的建立及其可靠性研究

Development of 3?multiplex and 4?multiplex PCR amplifying both DMD gene and SRY gene on single cell and the analysis of their reliability.

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 胡冬贵黄艳仪黎青孙筱放

【Author】 Hu Donggui,Huang Yanyi,Li Qing ,Sun Xiaofang.(Guangzhou Institute of Obstetrics and Gynacology Guangzhou 2nd People′s Hospital,510150)

【机构】 广州市第二人民医院广州市妇产科研究所!510150

【摘要】 种植前遗传学诊断(preimplantation geneticdiagnosis,PGD) 又称胚胎种植前遗传学诊断,是基于体外受精(in vitrofertilization,IVF)和早期胚胎活检(earlyembryo biopsy)技术基础之上的一种新的遗传病产前诊断的方法。假肥大型肌营养不良症(DMD/BMD)作为一种常见的X- 连琐隐性致死性遗传病,是国际上PGD界最早选择进入PGD 临床应用的几种遗传病之一。本文报道我们所建立的DMD基因和SRY 基因((sex - determination region Y,SRY) 单淋巴细胞三重(DMD) 基因外显子19,48 及SRY基因)及四重(DMD基因外显子17 、44 、45 及SRY 基因) 套式PCR技术及其可靠性分析。采取外周血标本制备单淋巴细胞悬液,应用上述三重或四重套式PCR 分析50 个正常男性单淋巴细胞,结果显示DMD 基因外显子17 、19、44 、45、48 及SRY 基因单淋巴细胞PCR 扩增成功率分别为92 % 、96 % 、94% 、96% 、94 % 以及94- 96% 。进一步分析50 个正常女性以及50 个DMD 男性患者(缺失DMD 基因外显子44 ?

【Abstract】 Preimplantation genetic diagnosis (PGD), a new prenatal diagnosis which can be offered to the couples who are at risk to give births to genetically affected offspring,is based on the techniques of in vitro fertilization (IVF) and early embryo biopsy.As one of the most common X?linked lethal genetic diseases,Duchenne muscular dystrophy(DMD) is one of the first group of genetic diseases which were chosen to be evaluated the possibility of clinical PGD.Here we present that the development of 3?multiplex(including DMD gene exon19,48 and SRY gene)and 4?multiplex(including DMD gene exon17 44,45and SRY gene)PCR amplifying both DMD gene and SRY gene on single lymphocytes and the analysis of their reliability.After analysis of 50 single normal male lymphocytes with these techniques,we found the successful amplification rates on single lymphocytes for DND gene exon17,19,44,45,48,and SRY gene are 92%,96%,94%,96%,94%and 94?96%respectively.We also found that the total amplification accurate rate for 3?multiplex and 4?multiplex are 96%(607/630)and 96%(807/840) respectively along with total false positive amplification rate 4.4%(4/90)and 3.3%(4/120) respectively after further analysis of 50 normal female lymphocytes and 50 DMD patient lymphocytes carrying a DMD gene deletion mutation involved exon44?49. Our results suggested that these techniques can be used for clinical PGD application which can analyze both sex and deletion mutation of DMD gene of the embryos at risk of being affected in DMD families carrying DMD gene deletion mutations involved exon17,19,44,45 and 48.These techniques are better than those only based on either sexdetermination of DMD deletion analysis which are available so far.

【基金】 广州市科委重点项目
  • 【文献出处】 中国优生与遗传杂志 ,CHINESE JOURNAL OF BIRTH HEALTH & HEREDITY , 编辑部邮箱 ,1999年05期
  • 【被引频次】10
  • 【下载频次】102
节点文献中: 

本文链接的文献网络图示:

本文的引文网络